Alkermes (ALKS) Other financing activities (2010 - 2026)

Alkermes' (ALKS) quarterly Other financing activities came in at $15.7 million in Q1 2026, down 46.78% year-on-year from $29.5 million in Q1 2025, and up 40.58% on a QoQ basis from $11.2 million in Q4 2025.

Alkermes (ALKS) Other financing activities (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Other financing activities data on file, last reported at $15.7 million in Q1 2026.

  • On a quarterly basis, Other financing activities fell 46.78% year-over-year to $15.7 million in Q1 2026; TTM through Mar 2026 was $29.6 million, a 35.48% decrease from a year earlier, with the FY2025 full-year figure at $43.4 million, up 57.45% from the prior year.
  • Other financing activities for Q1 2026 stood at $15.7 million, up from $11.2 million in the prior quarter.
  • Over the last five years, Other financing activities for ALKS reached as high as $29.5 million in Q1 2025 and fell as low as $622000.0 in Q3 2025.
  • Historically, Other financing activities has averaged $7.2 million across 5 years, with a median of $3.1 million in 2023.
  • Across the five-year window, Other financing activities surged 398.97% in 2024 and sank 88.73% in 2025, its largest moves.
  • Year by year, Other financing activities stood at $780000.0 in 2022, then soared by 111.15% to $1.6 million in 2023, then surged by 398.97% to $8.2 million in 2024, then soared by 36.02% to $11.2 million in 2025, then soared by 40.58% to $15.7 million in 2026.
  • Per Business Quant data, the three most recent Other financing activities figures were $15.7 million in Q1 2026, $11.2 million in Q4 2025, and $622000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.71 Mn
Mar 31, 2026 15.71 Mn
Dec 31, 2025 11.18 Mn
Dec 31, 2025 11.18 Mn
Sep 30, 2025 622,000.00
Sep 30, 2025 622,000.00
Jun 30, 2025 2.08 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 29.53 Mn
Mar 31, 2025 29.53 Mn
Dec 31, 2024 8.22 Mn
Dec 31, 2024 8.22 Mn
Sep 30, 2024 5.52 Mn
Sep 30, 2024 5.52 Mn
Jun 30, 2024 2.61 Mn
Jun 30, 2024 2.61 Mn
Mar 31, 2024 11.23 Mn
Mar 31, 2024 11.23 Mn
Dec 31, 2023 1.65 Mn
Dec 31, 2023 1.65 Mn